At a glance
- Thymoquinone is the main studied compound in black seed oil.
- Unusually for a botanical, it has a real body of human clinical trials behind it.
- A meta-analysis of randomised trials found improved SOD, a key antioxidant enzyme.
- Trials vary widely in size, preparation and quality — the picture is promising, not settled.
- It may affect how the body processes certain medications. Check with your doctor if you take any.
Thymoquinone is the compound that gets black seed oil taken seriously. It is the plant's main bioactive constituent, and it is the reason Nigella sativa appears in research databases far more often than most supplement botanicals.
What thymoquinone is
Black seed oil is pressed from the seeds of Nigella sativa, an annual herb also called black cumin or black caraway. Thymoquinone is a quinone compound credited with most of the plant's studied antioxidant and anti-inflammatory activity.
What human research has found
Black seed is unusual among botanicals in having a meaningful body of human clinical trials rather than only laboratory work.
Antioxidant status. A meta-analysis of randomised controlled trials found that Nigella sativa supplementation significantly improved superoxide dismutase, one of the body's primary antioxidant enzymes.
Metabolic markers. Reviews of clinical trials have reported effects on fasting glucose and lipid measures. These were studies in clinical populations, examining biomarkers rather than testing a supplement as a treatment — an important distinction, and not a reason to use black seed oil in place of prescribed care.
Cardiovascular risk factors. A 2025 systematic review and dose-response meta-analysis pooled 82 randomised controlled trials examining Nigella sativa and cardiovascular risk factors, with effects appearing greater at higher doses.
How it appears to work
In laboratory and animal research, thymoquinone's effects are linked to scavenging free radicals, upregulating the body's own antioxidant enzymes, and dampening inflammatory signalling including the NF-κB pathway. These mechanisms are consistent across preclinical work and help explain the antioxidant results seen in human trials.
The honest caveats
The research is promising but not settled. Many trials are small, use different preparations and doses, and vary in quality — which is exactly why review authors call for larger standardised studies.
Black seed oil is best understood as a well-supported wellness botanical, not a substitute for medical care. Thymoquinone can also affect how the body processes certain medications, so anyone on prescription drugs should check with a healthcare provider first.
Why it is paired with oregano oil
Thymoquinone and carvacrol are two different antioxidant compounds acting through complementary pathways, which is the rationale for combining them in one softgel. Our formula includes 200mg of black seed oil alongside 165mg of carvacrol per serving.
See Cures For Life Oil of Oregano with Black Seed Oil
Frequently asked questions
Is thymoquinone the same as black seed oil?
No. Thymoquinone is one compound within the oil. The oil also contains fatty acids, plant sterols and trace nutrients.
How much thymoquinone should a product contain?
There is no established target. Most labels state black seed oil content rather than thymoquinone, because concentration varies with seed quality and extraction.
Can it interact with medication?
Possibly. Thymoquinone may affect how the body metabolises certain drugs. Speak to your doctor or pharmacist if you take anything regularly.
References
- Effect of Nigella sativa Supplementation on Oxidative Stress and Antioxidant Parameters: A Meta-Analysis of Randomized Controlled Trials. The Scientific World Journal. 2020. PMC7225850
- Tavakkoli A, Mahdian V, Razavi BM, Hosseinzadeh H. Review on Clinical Trials of Black Seed (Nigella sativa) and Its Active Constituent, Thymoquinone. J Pharmacopuncture. 2017;20(3):179-193. PMC5633670
- Does Nigella sativa supplementation improve cardiovascular disease risk factors? A GRADE-assessed systematic review and dose-response meta-analysis of 82 RCTs. 2025. ScienceDirect
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This article is general information and is not medical advice.
